These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17918707)

  • 1. [Expression of ARA55 mRNA in prostate carcinoma tissues and its significance].
    Yang NQ; Li RS; Li D; Sha JJ; Li P; Wang YX
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):696-9. PubMed ID: 17918707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of TGF-beta1 mRNA in prostate carcinoma tissues and its significance].
    Li ZL; Yang Y; Li ZH; Kong CZ
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):511-3. PubMed ID: 16078668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.
    Miyoshi Y; Ishiguro H; Uemura H; Fujinami K; Miyamoto H; Miyoshi Y; Kitamura H; Kubota Y
    Prostate; 2003 Sep; 56(4):280-6. PubMed ID: 12858356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance].
    Liu BQ; Wu YD; Wei JX; Zhang T; Liu RL; Ma TX
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):997-1001. PubMed ID: 18077911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of apoptosis inhibitor gene Livin in prostate cancer and its clinical implication].
    Song T; Hong BF; Gao JP; Zhang L; Cai W
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):30-3. PubMed ID: 18297808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
    Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
    Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and implication of cyclooxygenase-2 mRNA in prostate cancer].
    Yang MS; Xia SJ; Liu HT; Sun XW; Han BM; Wu JT; Lu J; Ling GM; Tang XD
    Zhonghua Nan Ke Xue; 2006 Feb; 12(2):159-61. PubMed ID: 16519157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
    Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
    Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].
    Tao ZH; Mao XL; Wang CH; Chen XD; Yu KY; Weng ZL; Hu YP; Zhang XH; Xie H; Wang OC; Song QT; Li CD; Chen ZG
    Zhonghua Nan Ke Xue; 2007 Feb; 13(2):130-3. PubMed ID: 17345768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [P53 expression and its clinical significance in prostatic carcinoma].
    Jiang T; Jiang H; Song XS; Li XC; Li QL
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):448-51, 454. PubMed ID: 15999492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of urine DD3/PSA mRNA ratio by duplex TaqMan RT-PCR assay and evolution of its primary application].
    Chen FP; Chen LL; Shen M; Chen W; Tao ZH; Wu XL; Hu YP; Li CD; Chen ZG; Chen XD
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):261-4. PubMed ID: 18361839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues.
    Yang B; Chen J; Zhang X; Cao J
    Auris Nasus Larynx; 2009 Dec; 36(6):682-7. PubMed ID: 19427146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
    Wikström P; Marusic J; Stattin P; Bergh A
    Prostate; 2009 Jun; 69(8):799-809. PubMed ID: 19189305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma.
    Wei SH; Lin F; Wang X; Gao P; Zhang HZ
    Acta Histochem; 2008; 110(1):59-65. PubMed ID: 18054374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.
    Stavropoulou P; Gregorakis AK; Plebani M; Scorilas A
    Clin Chim Acta; 2005 Jul; 357(2):190-5. PubMed ID: 15893744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.